David A. Lovejoy, PhD, Chief Scientific Officer Dr. David Lovejoy is a cofounder of Protagenic Therapeutics Inc. He holds a PhD in Neuroendocrinology from the University of Victoria (Victoria, BC) and spent three years at the Clayton Foundation Laboratories for Peptide Biology at the Salk Institute (San Diego, CA) as a postdoctoral fellow. Dr. Lovejoy accepted his first academic appointment at the University of Manchester (Manchester, UK), one of United Kingdom’s top-ranking research universities. He joined the University of Toronto (Toronto, ON) in 2000 and is currently Professor of Neuroendocrinology in the Department of Cell and Systems Biology. He is the author of more than 130 publications including a textbook on neuroendocrinology.
|
